DOCSLIB.ORG

Igv, Victoria - Scott Mueller Mariapia Degli-Esposti Laura Mackay ALLERGIES ’NOTHING to SNEEZE AT’

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Igv, Victoria - Scott Mueller Mariapia Degli-Esposti Laura Mackay ALLERGIES ’NOTHING to SNEEZE AT’ ASI NEWSJUNE 2017 VACCINATE ME CAFFEINATE ME QUIZ ME TEACH ME Days of Immunology in Australia and Aotearoa CONTACT US Australasian Society 18 26 for Immunology Inc. PO Box 7108, ANDREW LEW: KEYSTONE SYMPOSIA Upper Ferntree Gully ASI Life Member on Viral Immunity and VIC 3156 Australia on the other side Tumor Immunology P: +61 3 9756 0128 [email protected] of ICI 2016 46TH ANNUAL SCIENTIFIC MEETING OF THE AUSTRALASIAN SOCIETy FOR IMMUNOLOGy Invited speakers will include: BURNET ORATOR FOUNDATION LECTURE PRESIDENT’s LECTURE LyNN CORCORAN GRAHAM MITCHELL CHRIS GOODNOW WALTER AND ELIZA HALL INSTITUTE OF MEDICAL FOURSIGHT ASSOCIATES PTY LTD GARVAN INSTITUTE OF MEDICAL RESEARCH, SYDNEY RESEARCH, VIC PLENARy SPEAKERS JUDITH ALLEN RAJIV KHANNA UNIVERSITY OF MANCHESTER, UK QIMR BERGHOFER, QLD JEAN-LAURENT CASANOVA yUTING MA THE ROCKEFELLER UNIVERSITY, USA CHINESE ACADEMY OF MEDICAL SCIENCES, CHINA SHANE CROTTy FABIENNE MACKAy LA JOLLA INSTITUTE FOR ALLERGY & IMMUNOLOGY, USA UNIVERSITY OF MELBOURNE, VIC MARIAPIA Degli-ESPOSTI LAURA MACKAy THE LIONS EYE INSTITUTE, WA UNIVERSITY OF MELBOURNE, VIC MICHAEL DUSTIN MARIA RESCIGNO UNIVERSITY OF OXFORD, UK UNIVERSITY OF MILAN, ITALY CAROLA VINUESA SARAH ROBERTSON AUSTRALIAN NATIONAL UNIVERSITY, ACT UNIVERSITY OF ADELAIDE, SA PHILIP HANSBRO FEDERICA SALLUSTO UNIVERSITY OF NEWCASTLE, NSW UNIVERSITY OF LUGANO, SWITZERLAND PAUL HERTZOG KEN SMITH HUDSON INSTITUTE OF MEDICAL RESEARCH, VIC CAMBRIDGE UNIVERSITY, UK SUSAN KAECH MARK SMyTH YALE UNIVERSITY, USA QIMR BERGHOFER, QLD BRISBANE CONVENTION & EXHIBITION CENTRE 27 NOVEMBER - 1 DECEMBER 2017 Registration and Abstract Submission now open www.asi2017.org TH 46 ANNUAL SCIENTIFIC MEETING OF ASI NEWSLETTER JUNE 2017 CONTENTS THE AUSTRALASIAN SOCIETy EDITORIAL: CUTTING EDGE SO THAT ANDREW LEW: ASI LIFE MEMBER AND ICI 2017 THERE IS BLOOD ON THE FLOOR ........................ 4 ORGANISING COMMITTEE MEMBER ..................18 FOR IMMUNOLOGy Joanna Roberts Colonial Cringe: Out, Sweet Smell of ICI2016 Success: In DAYS OF IMMUNOLOGY DOWN UNDER ............5 Kim McIntosh Invited speakers will include: Commitment to Immunology shines through Gabriela Khoury PRESIDENTORIAL ....................................................... 20 BURNET ORATOR FOUNDATION LECTURE PRESIDENT’s LECTURE Suzanne Heinzel SNAPSHOTS OF THE IMMUNE SYSTEM 2017 .. 6 LyNN CORCORAN GRAHAM MITCHELL CHRIS GOODNOW Gabriela Khoury SECRETARY’S REPORT ...............................................21 WALTER AND ELIZA HALL INSTITUTE OF MEDICAL FOURSIGHT ASSOCIATES PTY LTD GARVAN INSTITUTE OF MEDICAL RESEARCH, SYDNEY Elissa Deenick RESEARCH, VIC 500+ VACCINATIONS AT DOI VACCINATION PLENARy SPEAKERS CAFÉ IN MELBOURNE ................................................ 10 ASI VISITING SPEAKER PROGRAM ...................22 A great step towards ‘Preventable Pandemics’ Jo Kirman JUDITH ALLEN RAJIV KHANNA Kim Pham UNIVERSITY OF MANCHESTER, UK QIMR BERGHOFER, QLD BRANCH REPORTS ......................................................24 JEAN-LAURENT CASANOVA yUTING MA DAY OF IMMUNOLOGY, QUEENSLAND .............12 South Australia/Northern Territory - Iain Comerford THE ROCKEFELLER UNIVERSITY, USA CHINESE ACADEMY OF MEDICAL SCIENCES, CHINA Sumaira Z. Hasnain New Zealand - Ries Langley SHANE CROTTy FABIENNE MACKAy LA JOLLA INSTITUTE FOR ALLERGY & IMMUNOLOGY, USA UNIVERSITY OF MELBOURNE, VIC SCIENCE IN THE PUB: IgV, Victoria - Scott Mueller MARIAPIA Degli-ESPOSTI LAURA MACKAy ALLERGIES ’NOTHING TO SNEEZE AT’ ............ 14 Western Australia - Connie Jackaman THE LIONS EYE INSTITUTE, WA UNIVERSITY OF MELBOURNE, VIC South Australia/Northern Territories Queensland - Sumaira Z. Hasnain MICHAEL DUSTIN MARIA RESCIGNO Iain Comerford UNIVERSITY OF OXFORD, UK UNIVERSITY OF MILAN, ITALY TRAVEL REPORTS ........................................................26 PUB QUIZ ...........................................................................15 CAROLA VINUESA SARAH ROBERTSON Keystone Symposium Tumor Immunology, University of Otago, Dunedin AUSTRALIAN NATIONAL UNIVERSITY, ACT UNIVERSITY OF ADELAIDE, SA Whistler, Canada - Kirsten Ward Hartstonge Ries Langley PHILIP HANSBRO FEDERICA SALLUSTO Keystone Symposium on Viral Immunity, New UNIVERSITY OF NEWCASTLE, NSW UNIVERSITY OF LUGANO, SWITZERLAND DAY OF IMMUNOLOGY, WA .....................................16 Mexico, USA - Yew Ann Leong PAUL HERTZOG KEN SMITH Lelinh Duong & Connie Jackaman 2017 FIMSA Advanced Course; 2017 International HUDSON INSTITUTE OF MEDICAL RESEARCH, VIC CAMBRIDGE UNIVERSITY, UK Symposium on Autoimmunity, Beijing, China - SUSAN KAECH MARK SMyTH Delgertsetseg Chuluundorj, Hui-Fern Koay Godfrey, YALE UNIVERSITY, USA QIMR BERGHOFER, QLD Jonathan Chee FRONT COVER: REACTIVE LYMPHOCYTE - LYNNE WILSON, PUBLICATIONS OF INTEREST ...............................29 WESTERN AUSTRALIA, READ MORE ON PAGE 17 Our Sustaining Members 06 18 28 SUMPTUOUS CELLS Q: What was comparable WOOED BY BEIJING BRISBANE CONVENTION & EXHIBITION CENTRE The microscopic marvels to the work of 10 NMRHC Three young in the 'Snapshots of the grants, occupied three immunologists report back Immune System' are on years of his life, and was on their experience at the 27 NOVEMBER - 1 DECEMBER 2017 show. worthwhile enough that Advanced Immunology he'd probably do it again? Course in Beijing here. Registration and Abstract Submission now open Find out the answer... www.asi2017.org 03 EDITORIAL ASI NEWSLETTER JUNE 2017 CUTTING EDGE SO THAT THERE IS BLOOD ON THE FLOOR JOANNA ROBERTS “I call this ‘Flow Cytometry for the Masses’ and it will basically mean that you something. Someone approaches don’t need a cytometer to create high dimensional single cell data. We’ll see him to ask him if she can help. He explains he has lost his keys and CyTOF technology (in use) for the next 3-4 years and then after that people will is trying to find them. She asks, be doing this” Garry Nolan, May 2017, Stanford where did you lose them? He says, Garry was describing a technology and passion and compassion and over there, and gestures some in his lab to label individual cells fear and pain and death and hope way from where he is. She asks to generate gene data in a cell-by- all bound into one human story, why he is looking here then? He cell context which will generate the story of us and our species’ explains that it is dark over there data sets in a format that we can cancers. Mukherjee writes the and this is where the light is. think of like FCS files but with biography of cancer from its The streetlight effect is such an massive amounts of sequence earliest known example (a bone apt description of the context data per cell. cancer in a mummy) through to scientists can find themselves the start of the third millennium Hypothesis generating working in. Our techniques and (hence no immunotherapy which technologies get a fair bit of flack. tools let us look right here, in the we have to forgive him for). At Apparently grant reviewers hate light of the beautiful illumination one point in the book, Mukherjee them. But I like this quote from the of our current technology or tells the anecdote about the wonderfully under-stated Wendy paradigm. But we may very well streetlight effect. A version of it Fantl, Professor in the Dept of suspect that the answer, what goes: It is dark and a man is seen Gynaecology and Obstetrics at ever it looks like, is not here in on the street, under the street Stanford, ‘Well, they can call it a this light. It is over there, in the light, hunkered down furiously fishing expedition if they like, but dark, where it is much harder to searching the pavement for the fish are pretty good at the find. Here’s to all of you who work end’. outside the streetlight. I recently read the ‘The Emperor ‘Well, they can call it a fishing of all Maladies” by Siddhartha expedition if they like, but the fish www.flowjoanna.co.nz Mukherjee. Such a mix of hubris are pretty good at the end’. [email protected] Australasian Society for Immunology Inc. PO Box 7108, Upper Ferntree Gully VIC 3156 P: +61 3 9756 0128 E: [email protected] 04 DAY OF IMMUNOLOGY REPORTS ASI NEWSLETTER JUNE 2017 DAYS OF IMMUNOLOGY DOWN UNDER Commitment to Immunology shines through DAY OF IMMUNOLOGY 2017 GABRIELA KHOURY Day of Immunology National Coordinator and Social Media Manager This year has been my first as Day of Immunology National Coordinator. It is encouraging to see so many researchers excited about engaging with the public and promoting immunology. Every branch hosted a variety of events including public lectures, laboratory discovery tours, student workshops, a touring photography exhibition, a vaccination café and much more! Enjoy the articles in this issue of the newsletter provided by the local organising committees. COFFEE AND IMMUNITY – A FABULOUS COMBINATION. PHOTO COURTESY OF G KHOURY. Congratulations to all of the states, your hard work made for Australasian Society for Immunology Inc. a successful Day of Immunology To see more posts on the event check out Day of Immunology and ASI on PO Box 7108, Upper Ferntree Gully VIC 3156 2017. I can’t wait to see what we twitter (@dayofimmunology; @asimmunology) and Instagram (@doiaus). P: +61 3 9756 0128 E: [email protected] have installed for next year! 05 DAY OF IMMUNOLOGY REPORTS ASI NEWSLETTER JUNE 2017 SNAPSHOTS OF THE I have never seen so IMMUNE SYSTEM 2017 many selfies taken with GABRIELA KHOURY immunological images at once! It is only the second year of Snapshots of the Immune System exhibition and the responses to combining art
Load more

Recommended publications
  • The John Curtin School of Medical Research Annual Review 2012
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH ANNUAL REVIEW 2012 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2012 From the Director 3 The John Curtin School of Medical Organisation Chart 4 Research Committees 5 COMMUNITY 7 Official Opening of Stage 3 8 Launch of The John Curtin Medical Research Foundation 9 Professor Gordon Ada 10 Open Day 11 Community Activities 12 RESEARCH IN REVIEW 2012 15 Eccles Institute of Neuroscience 16 Department of Genome Biology 29 Department of Immunology 36 Department of Pathogens and Immunity 45 Department of Molecular Bioscience 47 Department of Translational Medicine 56 Australian Phenomics Facility 60 Biomolecular Resource Facility/Genome Discovery Unit 61 STAFF AND STUDENT ACHIEVEMENTS 63 VISITORS AND COLLABORATIONS 69 STAFF AND STUDENTS 85 Department of Genome Biology 86 Department of Immunology 87 Eccles Institute of Neuroscience 88 Department of Pathogens and Immunity 90 Department of Molecular Bioscience 90 Department of Translational Medicine 92 APF and Animal Services 92 School Services 94 School Administration 95 Students 96 PUBLICATIONS, PRESENTATIONS AND COMMUNITY OUTREACH 99 SUPPORT 129 Grants 130 Financial Overview 134 Donors 135 Sponsors 136 Annual Review 2012 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Zinkernagel. He will be sadly missed by his many friends and colleagues at the School, who have established the annual Gordon Ada New Investigator Award in his memory. In 2012, we finally completed the long and very necessary redevelopment project that resulted in the new John Curtin School of Medical Research building on the ANU campus. All our staff and students are once again under one roof, carrying out their research in state of the art laboratories and facilities.
    [Show full text]
  • Understanding Genomics
    Predict Diagnose Treat Understanding genomics A comprehensive guide brought to you by Garvan. Contents What is genomics? 4 A short history of DNA 5 Genomics information for a lifetime 7 Conversations about genomics 11 How does genome sequencing work? 12 Can I have my genome sequenced? 13 Genomics research at Garvan 14 Garvan’s genomics research programs 18 Genomics research centres 20 Useful terms 22 Predict Diagnose Treat 2 3 Professor Chris Goodnow FAA FRS Executive Director, Garvan Institute of Medical Research The Bill and Patricia Ritchie Foundation Chair Dear Friend, I’m Professor Chris Goodnow, Executive Director of the Garvan Institute of Medical Research in Sydney. I wanted to introduce myself and thank you for your interest in understanding genomics. Genomics is the study of genes and other information encoded in an individual’s genome—the complete set of instructions in their DNA. Each person has different DNA, unique just to you. Every disease has a genetic component. Through genomics research, we can further understand what our genetic information – and our gene or genetic variations – mean for our health. Garvan scientists use genomics research to understand more about disease and determine how to best diagnose, treat and prevent it. I hope you find this brochure informative and useful and consider joining our family, pioneering the future of medical research. Yours sincerely, Chris We see a future where an individual’s DNA is used to better predict, diagnose and treat disease. It’s within reach. 2 3 What is genomics? Genomics is the study of your genome – all the information encoded in your DNA.
    [Show full text]
  • Annual Report (March 2010-February 2011)
    EMBL Australia Annual Report [March 2010 – February 2011] 2 EMBL AUSTRALIA ANNUAL REPORT 2009–10 Contents Chairman’s report 2 Scientific Head’s report 3 About EMBL Australia 4 The European Molecular Biology Laboratory 4 2010 Highlights 5 2011 Outlook 6 Key activities 7 Launch by Minister Carr 7 Appointment of Scientific Head 8 EBI Mirror Facility and the National Bioinformatics Network 8 EBI Mirror at The University of Queensland 8 EMBL Australia Bioinformatics Network 9 International PhD Program 9 Partner Laboratory Network 9 Appointment of Edwina McGlinn 10 Appointment of Nicolas Platcha 11 Faculty Development Program 11 Sponsorship of BioInfoSummer 11 Governance 12 EMBL Australia participant expansion 12 Council 12 Appointment of new members 12 Council Members 12 Meetings 12 Planning and Finance Committee 13 Members 13 Meetings 13 Bioinformatics Committee 13 Members 13 Meetings 13 Staff 14 Australian visitors to EMBL 2010 15 Visitors to EMBL Australia 15 Financial report 16 Documents and Media releases 18 Funding & Stakeholders 20 Participants 20 Funding and in-kind support 20 Contact details inside back cover 1 Chairman’s report 2010 was a seminal year in the EMBL Australia initiative. Our official launch by Minister Carr in March coincided with the announcement of several key developments. These developments included the appointments of our Scientific Head and first Partner Laboratory Group Leaders, along with the announcement of a second node and associated national network for bioinformaticians. EMBL Australia’s participation is set to expand, with invitations accepted by the remaining Go8 universities to join EMBL Australia. This will extend direct involvement to a wider group of research institutions and expand the potential reach of EMBL Australia programs.
    [Show full text]
  • June 06.Indd
    NEWSLETTER Australasian Society for Immunology Incorporated PP 341403100035 ISSN 1442-8725 June 2006 Overview of the JCSMR Immunogenomics Laboratory 2006 Gerard Hoyne Overview they were able to reveal that the autoimmune but Dr Horikawa, a postodoctoral fellow in The Immunogenomics Laboratory at the regulator gene AIRE, which is expressed by the lab, has made the remarkable fi nding that John Curtin School of Medical Research in a subset of thymic epithelial cells, plays a the exact opposite is the case. The memory Canberra comprises four research groups critical role in establishing T cell tolerance B cell receptor is less active at inducing a working in concert to develop an integrated to self antigens in the thymus. In addition, subset of genes, and in this case less signal understanding of how our immune system is Adrian also identifi ed that defective signals means more antibody formation. controlled at the cellular and molecular level to cell death genes account for the inherited by circuits that are specifi ed in our genome resistance of T lymphocytes to clonal deletion Carola Vinuesa heads the Humoral sequence. Each of the groups focuses on in the thymus of NOD mice. Upon infection memory and Autoimmunity Group. a different element of a fundamental set with a virus or bacteria, B lymphocytes with Her group is investigating the cellular and of immune system decisions made at the the right antigen receptors to neutralize molecular events that regulate production level of individual immune system cells: infection are stimulated to switch the isotype and selection versus elimination of memory either to fi ght or to disarm.
    [Show full text]
  • THE JOHN CURTIN SCHOOL of MEDICAL RESEARCH Annual Review 2013
    THE JOHN CURTIN SCHOOL OF MEDICAL RESEARCH Annual Review 2013 ANU College of Medicine, Biology & Environment CONTENTS Annual Review 2013 The John Curtin School of Medical Research From the Director 3 Staff and student lists 87 Department of Genome Biology 88 Organisation Chart 4 Department of Immunology 90 Committees 5 Eccles Institute of Neuroscience 92 Department of Molecular Bioscience 94 Community 7 Department of Translational Medicine 96 Department of Pathogens and Immunity 96 Centenary of Canberra 2013 Australian Phenomics Facility 97 14th Frank and Bobbie Fenner Conference 8 School Administration 98 The John Curtin Medical Research Foundation Dinner 9 School Services 98 David Curtis Reading Room 10 The ACRF Biomolecular Resource Facility Open Day 2013 11 and Genome Discovery Unit 99 Community Activities 12 Students 100 Research in Review 2013 15 Publications, presentations and Eccles Institute of Neuroscience 16 community outreach 103 Department of Genome Biology 30 Publications 104 Department of Immunology 38 Staff Presentations 110 Department of Pathogens and Immunity 48 Student Presentations 117 Department of Molecular Bioscience 52 Community Outreach 121 Department of Translational Medicine 58 Australian Phenomics Facility 60 Support to JCSMR 131 The Imaging and Cytometry Facility 62 Grants 132 The ACRF Biomolecular Resource Facility Financial Overview 136 and Genome Discovery Unit 63 Donors 137 Staff and student achievements 65 Sponsors 138 Graduates 66 Prizes and Awards 67 Visitors and collaborations 71 Visitors 72 Collaborations 74 Annual Review 2013 1 2 The John Curtin School of Medical Research FROM THE DIRECTOR Following the opening of Stage 3 of our new building in 2012, JCSMR staff and students have enjoyed the opportunities provided by the new spaces, including the laboratories, and meeting rooms such as the Science Forum.
    [Show full text]
  • 2019 Annual Report
    Annual Report 2019 Garvan Institute of Medical Research Annual Report 2019 2019 Strength through collaboration Our vision Our values We see a future where everyone lives a longer, healthier life. Excellence Our mission Innovation We will harness all the information encoded in the genome Collaboration to better diagnose, predict, treat and prevent diseases that have the deepest impact on society. Community Integrity Respect Who we are, what we do The Garvan Institute of Medical Research brings together world-leading clinicians and basic and translational researchers. We are patient focused. Our researchers break down barriers between traditional scientific disciplines to find solutions to disease. Founded in 1963, Garvan’s researchers have made significant advances in genome, epigenome, protein and cell analysis technology. We have revealed causes and developed treatments for diseases including diabetes, osteoporosis, cancer, immune deficiency and autoimmunity. Today, Garvan’s mission builds on those advances, harnessing all the information encoded in our genome, from DNA to complex organ systems, to better diagnose, treat, predict and prevent disease. Garvan’s research has global impact. World-leading people pioneer discoveries across four intersecting research themes. We lead the field in medical genomics, epigenetics, and cellular genomics; cancer; diseases of immunity and inflammation; and diseases of ageing affecting bone, brain and metabolism. Our goal is to translate discovery into meaningful health benefits for those living with disease and their family. Patients, clinical trial cohorts and population cohorts are at the centre of Garvan’s research. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact.
    [Show full text]
  • 2018 Annual Report 2018 Our Year of Big Thinking, Collaboration and Discovery
    2018 Annual Report 2018 Our year of big thinking, collaboration and discovery. Our vision Our values We see a future where everyone lives a longer, Excellence healthier life. Innovation Our mission Collaboration We will harness all the information encoded in Community the genome to make pioneering discoveries that Integrity predict, treat and prevent diseases that have the deepest impact on society. Respect 2018 Garvan Annual Report Our values Who we are, what we do Aspirations Excellence Garvan is leading the nation in using genomic analysis • To become the most advanced institute in the to accelerate discovery and enable personalised, region in the adoption, application and integration Innovation precision medicine. of next-generation genomic and computational approaches and technologies in investigative and Collaboration Our researchers pioneer studies into some of the most translational research. difficult to solve and widespread diseases affecting the Community community today. Garvan is focused on understanding • To advance knowledge in our key areas of critical the molecular and cellular processes in health and mass that will lead to better understanding, reduced Integrity disease, putting people and patients at the centre of incidence and improved treatments for cancer, leading-edge local and global research expertise and immune deficiency, inflammatory and autoimmune Respect networks as the basis for developing future preventions diseases including diabetes, osteoporosis, and and treatments. diseases of ageing affecting the brain and other organs. For 56 years, Garvan scientists have been achieving significant breakthroughs in the understanding and • To attract, develop and support exceptionally talented treatment of diseases. researchers with leading-edge programs addressing key conceptual and practical questions in human biology, and the translation of new knowledge and technologies into clinical applications.
    [Show full text]
  • 2017 Annual Report GARVAN INSTITUTE of MEDICAL RESEARCH MISSION and VISION
    BREAKTHROUGH MEDICAL RESEARCH 2017 Annual Report GARVAN INSTITUTE OF MEDICAL RESEARCH MISSION AND VISION To make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human Respect Passion health. Garvan’s ultimate goal is prevention and treatment of major diseases. Collaboration Values Excellence Innovation Integrity Who we are, Aspirations • To attract, develop and support exceptionally talented what we do • To become the most researchers with leading‑edge advanced institute in the programs addressing key Garvan is leading the nation region in the adoption, conceptual and practical in using genomic analysis to application and integration of questions in human biology, accelerate discovery and enable next‑generation genomic and and the translation of new personalised, precision medicine. computational approaches and knowledge and technologies technologies in investigative into clinical applications. Our researchers pioneer and translational research. studies into some of the most • To embrace and uphold a culture widespread diseases affecting • To advance knowledge in our of collegiality, collaboration, the community today. Garvan is key areas of focus that will inclusivity, consideration, focused on understanding the lead to better understanding, safety, transparency, and role of molecular and cellular reduced incidence and high ethical standards. processes in health and disease improved treatments for cancer, as the basis for developing future osteoporosis, diabetes, obesity, • To engage stakeholders preventions and treatments. and immunological, skeletal and and the community with our neurological diseases, and achievements and research For 55 years, Garvan to influence health policy. vision so that we attract the scientists have been achieving significant government and significant breakthroughs donor support needed in the understanding and to empower our treatment of diseases.
    [Show full text]
  • Breakthrough Magazine June E Corkery Angele Labossiere Eric Swarbrick Please Visit Garvan.Org.Au/Previous-Seminars
    August 2018 | Issue 39 breakthrough Trust your gut How your bacteria could save you from type 2 diabetes Meet Professor Chris Goodnow, Garvan’s new Executive Director Living an extraordinary life with rare cancer Welcome NEW RESEARCH from our It’s DNA, but not as we know it Executive In a world first, our researchers Associate Professor Daniel Christ, Associate Professor Marcel Dinger and Director Dr Mahdi Zeraati found a new DNA structure – a twisted ‘knot’ they call the i-motif – inside cells. The iconic ‘double helix’ shape of DNA has captured the public imagination since 1953; however, it’s now known that DNA can exist Dear Garvan family, in a few other shapes – in a test tube, at least. Until now, the i-motif had never before been directly seen inside I’m so pleased to be able to introduce your August issue of living cells. In fact, scientists had debated whether i-motif Breakthrough and to have this opportunity to thank you for ‘knots’ would exist at all inside living things – a mystery your support. Many of you know me from my three years as that is now solved. Garvan researchers suspect i-motif Deputy Director here at Garvan. I’m honoured to have been DNA plays an important role in switching genes on or off. appointed as the Institute’s fourth Executive Director and build on the legacy of the Institute’s pre-eminent leaders. See the i-motif DNA at garvan.org.au/new-dna. I’d like to briefly share with you my vision for the future of Garvan, in which we continue our progress towards precision medicine based on each person’s DNA.
    [Show full text]
  • Garvan Institute's Guide to Positive Ageing
    Positive ageing A comprehensive guide brought to you by Garvan. PB 1 Contents Introduction 1 What is healthy ageing? 2 What happens to your body as it ages 4 Diseases of ageing 12 Healthy ageing – what you can do 14 Garvan & diseases of ageing 16 Medical Genome Reference Bank 24 We see a future where everyone lives longer, healthier lives. 1 Professor Chris Goodnow FAA FRS Executive Director, Garvan Institute of Medical Research The Bill and Patricia Ritchie Foundation Chair Dear Friend, I’m Professor Chris Goodnow, Executive Director of the Garvan Institute of Medical Research, one of Australia’s premier research facilities. I wanted to introduce myself and thank you for requesting our brochure on positive ageing. As precision medicine and advances in healthcare enable people to live longer than ever before, the ability to live not only long, but healthy lives is becoming increasingly critical. We know that ageing healthily relies on a complex mix of genetic, environmental and social factors. However, there are actions that can be taken now to help ensure that older adults maintain their physical and emotional health, whatever their age or circumstances. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact in order to create a future where people can live longer, healthier lives. Yours sincerely, Chris We see a future where an individual’s DNA is used to better predict, diagnose and treat disease. It’s within reach. 1 What is healthy ageing? With age comes the increased risk of disease or infirmity.
    [Show full text]
  • Mutations, Tolerance Checkpoints, Autoimmunity and Lymphoid Cancer
    Mutations, tolerance checkpoints, autoimmunity and lymphoid cancer PROFESSOR CHRISTOPHER C GOODNOW FAA FRS Executive Director, Garvan Institute of Medical Research ABSTRACT Distinguishing self from microbe is a fundamental problem for adaptive and innate immune receptors, balancing between the need for specificity and polyreactivity. Self-reactive antibodies are displayed as surface receptors on many B lymphocytes, and continuously signal responses within the B cell upon binding self antigens. A series of checkpoints and feedback mechanisms normally prevent these signals from activating relentless B cell proliferation and the potential for autoimmunity or lymphoma/leukemia. Here I will describe recent experiments analysinghow cells bypass these checkpoints by acquiring somatic mutations in the immunoglobulin V-regions and in lymphoma driver genes. 31 Thursday 1 August, 2019 ABOUT THE PRESENTER 1:00 - 2:00pm Professor Chris Goodnow FAA FRS is Executive Director of the Garvan Institute of Medical Research, holds The Bill and Patricia Ritchie Foundation H1 Lecture Theatre, Chair as Head of the Immunogenomics Laboratory at Garvan, and is Professor and Director of the Cellular Genomics Futures Institute at UNSW 20 Chancellors Walk Sydney. Chris trained in veterinary medicine and surgery, immunochemistry, Clayton campus and immunology at the University of Sydney and in DNA technology at Stanford University. Chris is internationally recognised for discovering and establishing the concept of sequential checkpoints for the immune system to tolerate “self” while fighting off “foreign” infections, laying the scientific foundation for the recent success of checkpoint inhibitor drugs to activate immune destruction of “self” cancer cells. He pioneered the use of genome sequencing to reveal how the body’s phenotype results from its’ genotype – “phenomics”.
    [Show full text]
  • Let Them Eat Cake Celebrating the Day of Immunology Throughout Australasia
    2016 ASI JUNE NEWSLETTER Let them eat cake Celebrating the Day of Immunology throughout Australasia Also in this issue Contact Us Australasian Society for Immunology Inc. • Knowledge Nation - Misty • Jaw-dropping beauty from PO Box 7108, Upper Ferntree Gully VIC 3156 Jenkins and DNA Nation Snapshots of the Immune Australia • Getting the news across - Peter system exhibition in Melbourne P: +61 3 9756 0128 Doherty interviewed by Erika • More delcious pictures of cake! E: [email protected] Duan International Congress of Immunology 2016 IMMUNOTHERAPY: HARNESSING THE POWER OF THE IMMUNE SYSTEM www.ici2016.org ICI 2016 Hosted by Invitation from the ICI 2016 President ICI 2016 promises to be an unforgettable event that will bring together delegates from all over the world. We anticipate over 3000 participants, including international leaders at the forefront of the discipline that will present the most recent advances in basic immunology and clinical treatments. This is an opportunity to be part of a major international immunology meeting in Australia as the last ICI was held in Sydney back in 1977. The Congress will provide a key networking and educational interface for colleagues from industry, university, health providers and independent research organisations to come together. Jose Villadangos President, International Congress of Immunology 2016 Peter Doherty Institute and Bio21 Institute, The University of Melbourne AXM0440 ICI 2016 Double Page Spread update.indd 2 13/05/2016 11:13 AM SOME OF THE CONFIRMED SPEAKERS Shizuo
    [Show full text]